Given the known role of ICOS in the development of follicular helper T cells, tumour-infiltrating lymphocytes (TILs) from the virus-treated tumours were characterized for the expression of Tfh lineage-specific markers (CD4+FoxP3−CXCR5+PD-1+ICOS+). This evidence concerns the gene ICOS and neoplasm.